期刊文献+

pT1b期食管鳞状细胞癌开放手术与微创食管切除术后预后分析 被引量:6

Prognostic analysis of pT1b esophageal squamous cell carcinoma after open or minimally invasive esophagectomy
原文传递
导出
摘要 目的比较微创食管切除术与传统开放食管切除术对pT1b期食管鳞状细胞癌(ESCC)患者近远期疗效之间的差异。方法回顾性分析2015~2018年于苏北人民医院胸外科行手术治疗并且术后病理确诊为pT1b期ESCC 162例患者的临床病理资料。根据手术方式分为微创手术(MIE)组和开放手术(OE)组。其中OE组共76例,男55例、女21例,平均年龄(63.3±5.6)岁;MIE组共86例,男60例、女26例,平均年龄(64.7±6.1)岁。比较两组患者的围术期资料并进行随访。采用Kaplan-Meier和log-rank检验对两组生存曲线进行比较,并利用Cox比例风险回归模型分析预后因素。结果与OE组相比,MIE组的术中出血量更少[(119.8±70.0)mL vs.(210.5±136.2)mL,P<0.001]、术中清扫淋巴结数量更多[(19.1±7.4)枚vs.(13.8±5.9)枚,P<0.001]、术后肺部感染发生率更低(9.3%vs.21.1%,P=0.036),但MIE组的手术时间[(240.0±52.4)min vs.(179.5±35.7)min,P<0.001]更长。162例患者中21例出现淋巴结转移,淋巴结转移率13.0%。至随访结束时共有19例患者死亡,术后1年、3年、5年总生存率(OS)分别为97.5%、88.8%和82.9%;31例患者出现复发转移,术后1年、3年、5年无病生存率(DFS)分别为95.1%、80.9%和75.6%;两组的OS和DFS差异无统计学意义。OS的多因素Cox回归分析结果发现淋巴结转移、吻合口瘘和乳糜胸是影响患者OS的独立危险因素。DFS的多因素Cox回归分析结果发现淋巴结转移、吻合口瘘、乳糜胸和脉管癌栓是影响患者DFS的独立危险因素。结论MIE可以达到与OE相同的远期疗效,并且术中出血量更少、清扫的淋巴结数目更多、术后肺部感染发生率更低,但手术时间更长。 Objective To compare the short-term and long-term effects of minimally invasive esophagectomy(MIE)and traditional open esophagectomy(OE)in patients with stage T1b esophageal squamous cell carcinoma(ESCC).Methods We retrospectively analyzed the clinical pathology data of 162 patients undergoing thoracic surgery at Northern Jiangsu People's Hospital from 2015 to 2018 whose pathological diagnosis was stage pT1b ESCC.According to the surgical approach,they were divided into MIE group and OE group.There were 55 males and 21 females in the OE group,with an average age of 63.3±5.6 years,and 60 males and 26 females in the MIE group,with an average age of 64.7±6.1 years.The preoperative,intraoperative and postoperative data of the two groups were compared and followed up.Survival data were compared using Kaplan-Meier and log-rank tests between the two groups,and Cox proportional hazard regression models were used to analyze prognostic factors.Results Compared with the OE group,the intraoperative bleeding volume of the MIE group was less(119.8±70.0 mL vs.210.5±136.2 mL,P<0.001),and the lymph nodes dissected during the operation were more(19.1±7.4 vs.13.8±5.9,P<0.001),the rate of postoperative pulmonary infections was lower(9.3%vs.21.1%,P=0.036),but the operation time was longer(240.0±52.4 min vs.179.5±35.7 min,P<0.001).Twenty-one patients had lymph node metastasis,and the lymph node metastasis rate was 13.0%.At the end of the follow-up,19 patients died,and the overall survival(OS)at 1 year,3 years,and 5 years after operation were 97.5%,88.8%and 82.9%,respectively;31 patients had recurrence and metastasis,and the disease-free survival(DFS)rate at 1 year,3 years,and 5 years after operation was 95.1%,80.9%and 75.6%.There was no significant difference in OS and DFS between the two groups.Multivariate Cox regression analysis of OS found that lymph node metastasis,anastomotic fistula and chylothorax were independent risk factors for OS.Multivariate Cox regression analysis of DFS found that lymph node metastasis,anastomotic fistula,chylothorax,and vascular cancer thrombus were independent risk factors for OS.Conclusion MIE can achieve the same long-term effects as OE,with less intraoperative bleeding,more lymph nodes dissected,and lower incidence of postoperative pulmonary infections,but it takes longer operation time.
作者 柳林 张勇 王霄霖 束余声 LIU Lin;ZHANG Yong;WANG Xiaolin;SHU Yusheng(Department of Thoracic Surgery,Second Affiliated Hospital of Dalian Medical University,Dalian,116044,P.R.China;Department of Thoracic Surgery,Northern Jiangsu People’s Hospital,Yangzhou,255001,Jiangsu,P.R.China)
出处 《中国胸心血管外科临床杂志》 CSCD 北大核心 2021年第2期225-232,共8页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 江苏省卫生厅科研基金面上指导性课题(Z201314)。
关键词 食管癌 鳞状细胞癌 T1b期 预后 外科手术 Esophageal cancer squamous cell carcinoma stage T1b prognosis surgery
  • 相关文献

参考文献9

二级参考文献63

  • 1曲家骐,侯维平,高昕,滕洪,史宁江,李铸,于修义.电视胸腔镜食管癌切除术八例初步报告[J].中华外科杂志,1996,34(2):84-86. 被引量:57
  • 2RICE T,RUSCH V W,APPERSON-HANSEN C,et al.Worldwide esophageal cancer collaboration[J].Dis Esophagus,2009,22(1):1-8.
  • 3FANG W,CHEN W,MAO T,et al.Selective threefield lymphadenectomy for thoracic esophageal squamous carcinoma[J].Dis Esophagus,2007,20(3):206-211.
  • 4EGUCHI T,NAKANISHI Y,SHIMODA T,et al.Histopatholngical criteria for additional treatment after endoscopic mucosal resection for esophageal cancer:analysis of 464 surgically resected cases[J].Mod Pathol,2006,19(3):475-480.
  • 5WIJNHOVEN B P,TRAN K T,ESTERMAN A,et al.An evaluation of prognostic factors and tumor staging of resocted carcinoma of the esophagus[J].Ann Surg,2007,245(5):717-725.
  • 6SIEWERT J R,STEIN H J.Lymph-node dissection in squamous cell esophageal cancer-who benefits?[J].Laagenbeck's Arch Surg,1999,384(2):141-148.
  • 7FANG W T,CHEN W H.Current trends in extended lymph node dissection for esophageal carcinoma[J] ,Asian Cardiovasc Thorac Ann,2009,17(2):208-213.
  • 8TACHIMORI Y,KATO H,WATANABE H,et al.Neckultrasonography for thoracic esophageal carcinoma[J].Ann Thorac Surg,1994,57(5):1180-1183.
  • 9中国抗癌协会食管癌专业委员会.可切除食管癌的手术治疗原则.食管癌规范化诊治指南[M].中国协和医科大学出版社,2010:36-50.
  • 10MIZOBUCHI S,KATO H,TACHIMORI Y,et al.Multiple primary carcinoma of the oesophagus[J].Surg Oncol,1993,2(4):249-253.

共引文献227

同被引文献73

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部